· wrinkle brain plays · 2 min read

Wrinkle Brain Plays

Plays for Execution on March 24, 2023. In the style of Dr. Seuss.

Plays for Execution on March 24, 2023. In the style of Dr. Seuss.

Tickers of Interest - TL;DR

Gamma Max Cross

  • GME 04/21 22.5P for $2.05 or less
  • RIOT 04/21 9.5P for $1.25 or less
  • AI 04/21 25P for $2.30 or less
  • GFI 04/21 12P for $0.35 or less
  • BKKT 04/21 1.5P for $0.15 or less

Delta Neutral Cross

  • BABA 04/21 86P for $3.75 or less
  • UBER 04/21 31.5C for $1.35 or less
  • DIS 04/21 96C for $3.15 or less
  • LQD 04/21 108.5P for $0.95 or less
  • MU 04/21 61P for $2.95 or less

A Trading Treatise - Why These Crayons Are the Best to Eat

In the hustle and bustle of trading stocks in a den,
Technical analysis makes you predict, then predict again.
Using past prices to find levels that matter,
And studying indicators so your profits don’t shatter.
We look at options, their interest we account,
With Delta and Gamma, our greeks we amount.
Portfolio-level greeks at different price lines,
Reveal where gammas are maxed and deltas align.
Some tickers respond to these levels you see,
Their prices bounce off like a bumblebee.
It’s off these levels we base our fine schemes,
For trading the market and catching green dreams.
Using a model, binomial in name,
We find where to enter our profit-seeking game.
A move in the stock or an IV swell,
Makes our plays all the better, as far as we can tell.\

Notes - A Wrinkle for Your Brain While You Rest

  • If prices have moved, take caution, indeed.
    Something has shifted, so carefully proceed.
  • Sell half on a double, and then let it ride,
    With the remaining shares, you can decide.
  • Risk up to one percent, if you dare,
    But if less certain, then tread with more care.
  • Remember, the trades were made ere market’s rise,
    So new price moves may change the prize.

FAQ - Queries from the Whos, Here and There

  • Mostly puts you trade, are you a bear so queer?
    • Nay, it’s just companies’ run-ups, we’re trying to steer clear.
  • Are you in all these plays, do you follow your rhyme?
    • No, dear friend, I share tools to help you climb.
  • If a new play’s mentioned, what of the old one in song?
    • Forget the old play, the new one’s come along.
  • Where are the crayons, the colors so bright?
    • Click the links, and they’ll come into sight.
  • Is this all tested, or just whimsy and play?
    • Yes, my dear Who, a Sharpe Ratio of 1.76, so they say.
  • What’s the performance, has it proved quite delightful?
    • A Sharpe Ratio of 1.88, and wins in 66% of the fights!
Use of HalfOnADouble's research is at your own risk. In no event should HalfOnADouble or any affiliated party be liable for any direct or indirect trading losses caused by any information in this report. You further agree to conduct your own research and due diligence, consult your own financial, legal, and tax advisors before making any investment decision concerning the transaction of any securities covered herein. You should assume that as of the publication date of any content, HalfOnADouble (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a position in all stocks (and/or options of the stock) covered herein, and therefore stands to realize significant gains in the event that the price of any stock covered herein moves as predicted. Following the publication of any report or letter, we intend to continue transacting in the securities covered herein, and we may be long, short, or neutral at any time hereafter regardless of our initial recommendation, conclusions, or opinions. This is not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction. HalfOnADouble is not registered as an investment advisor in the United States or have similar registration in any other jurisdiction. To the best of our ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources we believe to be accurate and reliable, and who are not insiders or connected persons of the stock covered herein or who may otherwise owe any fiduciary duty or duty of confidentiality to the issuer. However, such information is presented "as is," without warranty of any kind - whether express or implied. HalfOnADouble makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information or with regard to the results to be obtained from its use. All expressions of opinion are subject to change without notice, and HalfOnADouble does not undertake to update or supplement this report or any of the information contained herein.
Back to Blog